EnteroMedics is having an incredibly strong day in the market today, and for good reason. Earlier today, the company released 3 year data …
Stock
At the movement EnteroMedics Inc. (NASDAQ:ETRM) is under coverage by number of analysts. Buy rating has been given by 1 analysts to the company stock whereas no analyst given UNDERPERFORM rating to stock
NASDAQ
vBloc is unlikely to ever gain major traction. The stock has a history of major dilution. I was prompted to write this article by a February 9 press release from EnteroMedics (NASDAQ:ETRM) that indicated the results from the …
Wallet
In ETRM’s case the company is making a loss ... This sparked his interest in the stock market, building up a portfolio with his father’s guidance …
Wall Street
EnteroMedics Inc (NASDAQ:ETRM) saw its stock climb by 106% on Thursday after the company’s treatment for obesity, metabolic diseases, and other gastrointestinal disorders was implanted at two additional institutes, …
Where Is ETRM Stock Headed Next? EnteroMedics Inc (NASDAQ:ETRM) was down almost 25% by late-morning trading on Tuesday as ETRM stock continues to be a volatile share so far in 2017. Just a few weeks ago, …
Stock
Buz Investoes ETRM Stock Is Soaring (NASDAQ:ETRM) is not a stock for the faint of heart. The share prices of ETRM stock are back on top, rising by nearly 10% by the opening bell on Monday, continuing the recent …
Soaring
EnteroMedics Inc (NASDAQ:ETRM) has had a busy 2017 so far. After climbing by 1373% in five days starting on January 4, ETRM stock is now down over 43%. Like a lot of health and biotech stocks, President-elect Donald …
Climb
The stock's price fluctuated within the range of $6.50 - $10.17 during previous trading session. The latest Insider trade was made on 2 Jun 2016 where Delange (Peter M) Officer did a transaction type "Buy" in which 20000 …
Soaring